Malaria-induced interferon-γ drives the expansion of Tbethi atypical memory B cells.
Nyamekye Obeng-AdjeiSilvia PortugalPrasida HollaShanping LiHaewon SohnAbhijit A AmbegaonkarJeff SkinnerGeorgina S BowyerOgobara K DoumboBoubacar TraoreSusan K PiercePeter Dobbs CromptonPublished in: PLoS pathogens (2017)
Many chronic infections, including malaria and HIV, are associated with a large expansion of CD21-CD27- 'atypical' memory B cells (MBCs) that exhibit reduced B cell receptor (BCR) signaling and effector functions. Little is known about the conditions or transcriptional regulators driving atypical MBC differentiation. Here we show that atypical MBCs in malaria-exposed individuals highly express the transcription factor T-bet, and that T-bet expression correlates inversely with BCR signaling and skews toward IgG3 class switching. Moreover, a longitudinal analysis of a subset of children suggested a correlation between the incidence of febrile malaria and the expansion of T-bethi B cells. The Th1-cytokine containing supernatants of malaria-stimulated PBMCs plus BCR cross linking induced T-bet expression in naïve B cells that was abrogated by neutralizing IFN-γ or blocking the IFN-γ receptor on B cells. Accordingly, recombinant IFN-γ plus BCR cross-linking drove T-bet expression in peripheral and tonsillar B cells. Consistent with this, Th1-polarized Tfh (Tfh-1) cells more efficiently induced T-bet expression in naïve B cells. These data provide new insight into the mechanisms underlying atypical MBC differentiation.
Keyphrases
- poor prognosis
- plasmodium falciparum
- transcription factor
- acute lymphoblastic leukemia
- dendritic cells
- high glucose
- tyrosine kinase
- binding protein
- diabetic rats
- chronic myeloid leukemia
- immune response
- induced apoptosis
- hiv infected
- gene expression
- long non coding rna
- human immunodeficiency virus
- antiretroviral therapy
- hepatitis c virus
- working memory
- machine learning
- risk factors
- signaling pathway
- cell death
- artificial intelligence
- urinary tract infection
- type iii